- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 5, 2024 | 111.26M sh |
| Long Term Debt | Q3 2024 · Sep 30, 2024 | $2.03B |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $2.24B |
| Short Term Debt | Q3 2024 · Sep 30, 2024 | $500M |
| Short Term Debt | Q3 2024 · Dec 31, 2023 | $307M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $102M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $106M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $1.62B |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $1.68B |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $1.45B |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $1.21B |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $4.12B |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $4.16B |
| Current Assets | Q3 2024 · Sep 30, 2024 | $648M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $580M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $5.75B |
| Total Assets | Q3 2024 · Dec 31, 2023 | $5.84B |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 112.1M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 111.6M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $52M |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | $125M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $1.15 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.09 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $1.17 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.09 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $104M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $331M |
| Net Income | Q3 2024 · Sep 30, 2023 | $129M |
| Net Income | Q3 2024 · Sep 30, 2023 | $10M |
| Revenue | Q3 2024 · Sep 30, 2023 | $1.58B |
| Revenue | Q3 2024 · Sep 30, 2023 | $4.39B |